Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
XGEN

Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF

The XGEN Exchange Traded Fund (ETF) is provided by Xtrackers by DWS. It is built to track an index: MSCI ACWI IMI Genomic Innovation Select Screened 100 Index. The XGEN ETF provides physical exposure, so by buying it you actually own parts of all the 100 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

$37.30
N/A
Data as of 07/24/26
1D price range
N/A
52W price range
$28.64$39.09
YTD Perf.
+7.81%
YTD Flows
Annualized volatility
Fund AuM
€8.8M
Share class AuM
€8.8M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE000KD0BZ68
TER
0.25%
Inception date
7/12/2022
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 24, 2026
-10%-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
100.00%
Latest XGEN news

FAQ about XGEN

XGEN is a Passive ETF. This ETF provides exposure to Other Equities.
XGEN tracks the MSCI ACWI IMI Genomic Innovation Select Screened 100 Index - USD, through a full replication replication method.
XGEN carries a total expense ratio (TER) of 0.25%, indicating the annual cost for holding the fund.
XGEN was introduced to the market on July 12, 2022. It trades on Germany, among other exchanges
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF, XGEN, is provided by Xtrackers by DWS. Learn more about Xtrackers by DWS here.
XGEN oversees €8.8M in assets as of July 24, 2026.
XGEN follows a capitalizing, meaning it reinvests income within the fund.
As of June 30, 2026, XGEN has significant geographic allocations in USA, Switzerland and Netherlands.
As of June 30, 2026, XGEN focuses largely on Healthcare.
As of June 30, 2026, XGEN holds 100 positions in its portfolio, with 58.17% of assets concentrated in its top 15 holdings.
As of June 30, 2026, XGEN top three holdings include Natera, Inc., Illumina, Inc. and Agilent Technologies, Inc..
The base currency of XGEN is USD.
Data as of 06/30/26
Natera, Inc.
5.14%
Illumina, Inc.
4.79%
Agilent Technologies, Inc.
4.73%
Moderna, Inc.
4.58%
Danaher Corp.
4.52%
Vertex Pharmaceuticals, Inc.
4.35%
Lonza Group AG
4.11%
GSK Plc
3.95%
Guardant Health, Inc.
3.81%
argenx SE
3.74%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight